Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ABSI

Absci Corp

11.33

Jul 07 • 04:00PM ET -0.21 (-1.82%)

Healthcare Biotechnology USA Small NASD

Peers: RXRX SDGR CERT KYMR RYTM INCY NUVL BMRN KRYS AXSM

| Held by: ARKG XBI IWM VTI IWO IBB VXF SCHA IWC VTWO

Index	RUT
Market Cap	1.92B
Enterprise Value	1.80B
Income	-118.44M
Sales	1.84M
Book/sh	1.11
Cash/sh	0.74
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	140
IPO	Jul 22, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	1043.10
P/B	10.23
P/C	15.27
P/FCF	-
EV/EBITDA	-
EV/Sales	977.19
Quick Ratio	6.59
Current Ratio	6.59
Debt/Eq	0.03
LT Debt/Eq	0.01
Option/Short	Yes / Yes

EPS (ttm)	-0.83
EPS next Y	-0.70
EPS next Q	-0.19
EPS this Y	10.98%
EPS next Y	6.58%
EPS next 5Y	19.27%
EPS past 3/5Y	9.99% -9.45%
Sales past 3/5Y	-21.31% -10.14%
EPS Y/Y TTM	10.39%
Sales Y/Y TTM	-61.87%
EPS Q/Q	8.60%
Sales Q/Q	-81.76%
Earnings	May 07 AMC
EPS/Sales Surpr.	4.47% -82.89%

Insider Own	14.43%
Insider Trans	0.75%
Inst Own	69.06%
Inst Trans	1.73%
ROA	-55.34%
ROE	-63.89%
ROIC	-68.02%
Gross Margin	-520.81%
Oper. Margin	-7000.82%
Profit Margin	-6450.76%
SMA20	27.69%
SMA50	65.56%
SMA200	173.31%
Trades

Shs Outstand	155.35M
Shs Float	144.96M
Short Float	23.01%
Short Ratio	5.61
Short Interest	33.36M
52W High	12.06 -6.01%
52W Low	2.24 405.80%
Volatility	6.96% 11.50%
ATR (14)	0.97
RSI (14)	70.95
Beta	2.33
Rel Volume	0.70
Avg Volume	5.95M
Volume	4,142,629

Perf Week	-0.18%
Perf Month	54.36%
Perf Quarter	282.77%
Perf Half Y	213.85%
Perf YTD	224.64%
Perf Year	339.15%
Perf 3Y	686.81%
Perf 5Y	-
Perf 10Y	-
Recom	1.20
Target Price	13.11
Prev Close	11.54
Price	11.33
Change	-1.82%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-04-26	Initiated	Leerink Partners	Outperform	$12
May-28-26	Initiated	BTIG Research	Buy	$9
Jan-08-26	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$4.32
Oct-02-25	Initiated	JP Morgan	Overweight
Jul-03-25	Resumed	Morgan Stanley	Overweight	$7
Jan-22-25	Initiated	Needham	Buy	$9
Oct-02-24	Initiated	Guggenheim	Buy	$10
Jul-03-24	Initiated	Morgan Stanley	Overweight	$7
Mar-14-24	Initiated	Scotiabank	Sector Outperform	$13
Dec-05-23	Initiated	KeyBanc Capital Markets	Overweight	$3
May-04-23	Initiated	H.C. Wainwright	Buy	$4
Aug-12-22	Downgrade	JP Morgan	Overweight → Underweight
Jul-18-22	Initiated	Truist	Buy	$8
Mar-02-22	Resumed	Cowen	Market Perform
Feb-01-22	Initiated	Berenberg	Buy	$28
Nov-10-21	Downgrade	BofA Securities	Neutral → Underperform	$10
Oct-15-21	Resumed	Cowen	Market Perform
Aug-16-21	Initiated	Stifel	Hold	$28
Aug-16-21	Initiated	Credit Suisse	Outperform	$40
Aug-16-21	Initiated	Cowen	Market Perform

Show Previous Ratings

Jul-06-26 08:55AM	As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models (PR Newswire)
08:45AM	The Quantum Sector Hits an Inflection Point: Federal Money, Real Milestones, and a Security Race Running in Parallel (PR Newswire)
Jun-26-26 02:39PM	Healthcare stocks have become a haven for investors ditching tech (MarketWatch) +6.66%
06:27AM	Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy (Pharmaceutical Technology)
Jun-24-26 11:24PM	Why Did UAL, GLW, ABSI Stocks Surge To 52-Week Highs Today? (Stocktwits) +35.96%
03:55PM	Loading…
03:55PM	ABSI Stock Eyes Best Day Ever After Positive Hair Loss Drug Data, $100M Lilly-Backed Raise (Stocktwits)
08:59AM	Absci Shares Soar After Positive Early Clinical Results for Hair Loss Therapy (ABSI) (InvestorsHub)
08:07AM	Absci, FuelCell Energy surge premarket; Cerebras, FedEx tumble (Investing.com)
06:35AM	Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors (GlobeNewswire)
06:30AM	Absci Announces Positive Interim Phase 1 Data from the HEADLINE Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) (GlobeNewswire)
Jun-16-26 08:45AM	The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It (PR Newswire)
Jun-12-26 09:00AM	MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery (Business Wire)
May-20-26 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire) +6.91%
May-13-26 11:11AM	Marvell Stock Climbs After AMD Reveals Surprise Stake (GuruFocus.com)
May-07-26 04:05PM	Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results (GlobeNewswire)
09:28AM	Loading…
May-06-26 09:28AM	Absci Corp (ABSI) Q1 2026 Earnings Report Preview: What To Look For (GuruFocus.com) +6.06%
May-04-26 08:11PM	Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +14.23%
Apr-23-26 04:05PM	Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026 (GlobeNewswire) +7.88%
Apr-08-26 08:00AM	Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-25-26 08:30AM	Absci Corporation Q4 2025 Earnings Call Summary (Moby)
Mar-24-26 11:01PM	Absci Corp (ABSI) Q4 2025 Earnings Call Highlights: Strategic Advances and Financial Resilience (GuruFocus.com)
04:05PM	Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results (GlobeNewswire)
08:00AM	Absci Launches ABS-201 Endometriosis Advisory Board with Leading Experts from Yale, UCSF, Duke, and the Mayo Clinic (GlobeNewswire)
Mar-23-26 09:17AM	Earnings To Watch: Absci Corp (ABSI) Reports Q4 2025 Result (GuruFocus.com)
Mar-06-26 04:05PM	Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -8.11% +5.46%
Mar-03-26 08:00AM	Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer (GlobeNewswire) -8.21%
Mar-02-26 12:15PM	Absci Conference: Agentic AI Push and ABS-201 Hair-Loss Program Take Center Stage (MarketBeat)
Feb-24-26 08:00AM	Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026 (GlobeNewswire)
Feb-17-26 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jan-14-26 09:07PM	Absci Unveils Origin-1 AI Model, Teases 2025 Hair-Loss Data and Q4 Endometriosis Trial Launch (MarketBeat) -8.96%
02:13PM	Loading…
02:13PM	Analysts Cut Absci (ABSI) Target, Spotlight New Alopecia Therapy in Early Trials (Insider Monkey)
Dec-31-25 11:13AM	Absci Unveils Preclinical Data for AI-Designed ABS-201, Targeting a Novel Hormonal Pathway for Hair Loss Treatment (Insider Monkey)
Dec-30-25 12:18PM	Absci Corporation (ABSI) Announces First Participants Dosed In Phase 1/2a HEADLINE Trial (Insider Monkey)
Dec-27-25 07:43AM	Absci Corporation (ABSI) Draws Full Buy Consensus With 150% Upside Potential (Insider Monkey)
Dec-18-25 01:14AM	Absci Corporation (NASDAQ:ABSI)'s ABS-201 Shows Promise in Hair Loss Treatment, Analysts See Upside (Insider Monkey)
Dec-16-25 08:00AM	Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-12-25 10:15AM	AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave (PR Newswire) -5.21%
Dec-11-25 08:00AM	Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201 Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization (GlobeNewswire)
Dec-10-25 08:00AM	Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research (GlobeNewswire) +12.78%
Dec-05-25 10:37AM	ABSI Stock Up on Initiating Dosing in Androgenetic Alopecia Study (Zacks)
Dec-04-25 08:00AM	Absci Announces First Participants Dosed in Phase 1/2a HEADLINE Trial of AI-Designed Antibody ABS-201 for Androgenetic Alopecia (GlobeNewswire) +13.37%
06:05AM	10 AI Stocks Worth Buying Right Now (Motley Fool)
Nov-13-25 12:02AM	Absci Corp (ABSI) Q3 2025 Earnings Call Highlights: Strategic Shifts and Strong Cash Position ... (GuruFocus.com) -22.35%
Nov-12-25 05:25PM	Absci Corporation (ABSI) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results (GlobeNewswire)
Nov-11-25 07:28AM	Absci Corp (ABSI) Q3 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Nov-10-25 08:15AM	uniQure (QURE) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
Nov-06-25 09:15AM	Invivyd, Inc. (IVVD) Reports Q3 Loss, Lags Revenue Estimates (Zacks) -5.77%
Oct-29-25 04:05PM	Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025 (GlobeNewswire) -6.41%
Oct-27-25 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire) +5.39%
Oct-15-25 08:00AM	Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial (GlobeNewswire) +28.21%
Oct-13-25 12:12PM	2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk (MarketBeat)
Sep-21-25 09:26AM	Absci Corporation (ABSI) Secures $64M Financing to Drive AI Drug Discovery Through 2028 (Insider Monkey)
Sep-11-25 08:00AM	Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD (GlobeNewswire) +15.13%
Aug-25-25 04:05PM	Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg (GlobeNewswire)
Aug-20-25 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-13-25 03:12AM	Absci Corp (ABSI) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Revenue Challenges (GuruFocus.com) +5.05%
Aug-12-25 05:20PM	Absci Corporation (ABSI) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results (GlobeNewswire)
Aug-11-25 09:31AM	Absci Corp (ABSI) Q2 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Aug-07-25 10:00AM	SAB Biotherapeutics, Inc. (SABS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release (Zacks)
02:00AM	Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target (GlobeNewswire)
Aug-06-25 10:00AM	Absci Corporation (ABSI) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Aug-05-25 05:15PM	Amgen (AMGN) Beats Q2 Earnings and Revenue Estimates (Zacks)
Aug-04-25 05:15PM	Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
Jul-30-25 04:05PM	Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025 (GlobeNewswire)
Jul-25-25 09:56AM	Coya Therapeutics, Inc. (COYA) Surges 10.7%: Is This an Indication of Further Gains? (Zacks) -17.66%
Jul-24-25 08:45PM	Absci Announces Pricing of Public Offering of Common Stock (GlobeNewswire)
04:54PM	Absci Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Jul-11-25 07:15PM	Morgan Stanley Assumes Coverage on Absci Corporation (ABSI) with $7 Target (Insider Monkey)
Jul-07-25 08:30AM	iRhythm Technologies Announces Board Member Retirements and New Director Appointments (GlobeNewswire) -6.86%
08:00AM	Absci Appoints Biopharma Leader Mary Szela to Board of Directors (GlobeNewswire)
May-20-25 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-14-25 08:32AM	Q1 2025 Absci Corp Earnings Call (Thomson Reuters StreetEvents)
03:17AM	Absci Corp (ABSI) Q1 2025 Earnings Call Highlights: Transition to Clinical Stage and Strong ... (GuruFocus.com)
May-13-25 05:30PM	Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results (GlobeNewswire)
04:01PM	Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease (GlobeNewswire)
May-12-25 09:35AM	What To Expect From Absci Corp (ABSI) Q1 2025 Earnings (GuruFocus.com) +6.55%
Apr-14-25 04:05PM	Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025 (GlobeNewswire)
11:40AM	Absci: FDA Announcement Provides Only A Modest Tailwind (Seeking Alpha)
Apr-03-25 03:15PM	Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market (Seeking Alpha) -9.88%
Mar-31-25 07:15AM	Which Healthcare Stock Is the Best Buy Right Now? (MarketBeat) -7.04%
Mar-26-25 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire) -5.54%
Mar-21-25 10:57PM	Absci Corp (ABSI) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Mar-19-25 09:08AM	Q4 2024 Absci Corp Earnings Call (Thomson Reuters StreetEvents)
03:03AM	Absci Corp (ABSI) Q4 2024 Earnings Call Highlights: Strategic Collaborations and Financial ... (GuruFocus.com)
Mar-18-25 04:05PM	Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results (GlobeNewswire)
Mar-04-25 04:05PM	Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025 (GlobeNewswire)
04:00PM	Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
08:00AM	Absci to Participate in the KeyBanc Capital Markets Healthcare Forum (GlobeNewswire)
Mar-01-25 05:19PM	Why Absci Corporation (ABSI) is Skyrocketing So Far in 2025 (Insider Monkey)
Feb-18-25 08:00AM	Absci to Participate in the TD Cowen 45th Annual Health Care Conference (GlobeNewswire)
Feb-12-25 09:24AM	Is Absci Corp. (ABSI) the Best Nasdaq Stock Under $5 to Buy? (Insider Monkey)
Feb-11-25 09:00AM	FDA Approval Race: AI-Powered Innovations Reshape the Healthcare Landscape (PR Newswire) +13.39%
Jan-24-25 11:54AM	Absci Corporation (ABSI): Pioneering AI-Driven Antibody Discovery with a Buy Rating from Needham (Insider Monkey)
Jan-22-25 01:22PM	Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside (Benzinga) +25.16%
08:00AM	Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference (GlobeNewswire)
Jan-17-25 05:58PM	Healthcare AI Adoption Accelerates as Industry Eyes $125 Billion Growth by 2028 (PR Newswire) +11.03%
01:54PM	Absci Corporation (ABSI): AI in Biopharma Discovery (Insider Monkey)

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.

FounderMr. Sean McClain

Chief Business Officer & CFODr. Zachariah Jonasson Ph.D.

Senior VP & Chief Accounting OfficerMr. Todd Bedrick CPA

CVP of Finance & Head of Investor RelationsMr. Alexander Khan CPA

Chief Legal OfficerMs. Shelby Walker J.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Szela Mary T	Director	Jun 30 '26	Buy	11.54	12,900	148,866	21,300	Jul 06 04:06 PM
Pangalos Menelas N	Director	May 13 '26	Buy	5.36	37,453	200,748	232,308	May 13 04:05 PM
Busch Andreas	Chief Innovation Officer	Mar 12 '26	Buy	2.29	100,000	229,000	421,446	Mar 16 04:17 PM
Pangalos Menelas N	Director	Feb 27 '26	Buy	2.74	75,095	205,760	189,055	Mar 03 04:13 PM
McClain Sean	Chief Executive Officer	Feb 23 '26	Option Exercise	1.21	396,399	479,643	8,730,966	Feb 25 06:05 PM
McClain Sean	Chief Executive Officer	Feb 02 '26	Sale	2.99	26,761	80,015	8,334,567	Feb 04 04:52 PM
Jonasson Zachariah	CFO / CBO	Feb 02 '26	Sale	2.99	17,496	52,313	383,538	Feb 04 04:51 PM
VAN HOUTEN FRANS	Director	Dec 05 '25	Buy	3.72	40,000	148,800	63,320	Dec 09 04:04 PM
Pangalos Menelas N	Director	Sep 22 '25	Buy	2.66	95,785	254,788	113,960	Sep 24 04:03 PM
Bedrick Todd	SVP, CAO	Sep 22 '25	Buy	2.70	10,000	27,000	180,428	Sep 24 04:03 PM
Busch Andreas	Chief Innovation Officer	Jul 28 '25	Buy	3.04	50,000	152,000	327,264	Jul 29 08:37 AM

TLSI TriSalus Life Sciences Inc daily Stock Chart

Peers: MASS RXST SENS APYX VMD OFIX BFLY INMD LMAT MMSI

| Held by: IWM VTI IWO VXF IWC VTWO QQQS RSSL VTWV VTWG

Index	RUT
Market Cap	249.97M
Enterprise Value	227.91M
Income	-58.49M
Sales	44.88M
Book/sh	0.21
Cash/sh	0.92
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	102
IPO	Feb 08, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	5.57
P/B	19.52
P/C	4.42
P/FCF	-
EV/EBITDA	-
EV/Sales	5.08
Quick Ratio	5.46
Current Ratio	5.78
Debt/Eq	2.69
LT Debt/Eq	2.68
Option/Short	No / Yes

EPS (ttm)	-1.41
EPS next Y	-0.14
EPS next Q	-0.15
EPS this Y	84.24%
EPS next Y	50.86%
EPS next 5Y	-
EPS past 3/5Y	77.50% -140.62%
Sales past 3/5Y	53.85% -
EPS Y/Y TTM	-25.99%
Sales Y/Y TTM	39.64%
EPS Q/Q	107.57%
Sales Q/Q	-2.92%
Earnings	May 12 AMC
EPS/Sales Surpr.	118.99% -12.67%

Insider Own	38.04%
Insider Trans	5.07%
Inst Own	34.17%
Inst Trans	24.99%
ROA	-54.84%
ROE	-
ROIC	-58.02%
Gross Margin	85.07%
Oper. Margin	-62.45%
Profit Margin	-130.32%
SMA20	-0.91%
SMA50	4.85%
SMA200	-15.57%
Trades

Shs Outstand	61.41M
Shs Float	38.04M
Short Float	5.75%
Short Ratio	4.71
Short Interest	2.19M
52W High	7.95 -48.81%
52W Low	2.20 85.00%
Volatility	7.84% 9.04%
ATR (14)	0.35
RSI (14)	49.69
Beta	0.43
Rel Volume	0.72
Avg Volume	464.29K
Volume	333,928

Perf Week	-14.14%
Perf Month	23.33%
Perf Quarter	-0.25%
Perf Half Y	-33.28%
Perf YTD	-41.69%
Perf Year	-17.94%
Perf 3Y	-61.27%
Perf 5Y	-58.23%
Perf 10Y	-
Recom	1.00
Target Price	9.00
Prev Close	4.31
Price	4.07
Change	-5.57%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-13-25	Initiated	Lake Street	Buy
Dec-17-24	Initiated	Cantor Fitzgerald	Overweight	$10
Nov-11-24	Initiated	ROTH MKM	Buy	$11
Oct-25-24	Initiated	Northland Capital	Outperform	$12.50
Sep-16-24	Initiated	Oppenheimer	Outperform	$10
May-30-24	Initiated	Canaccord Genuity	Buy	$12

Jun-10-26 08:00AM	TriSalus Life Sciences to Host Virtual KOL Event on June 24 Featuring New Real-World Evidence for Pressure-Enabled Drug Delivery in Liver Cancer (Business Wire) +6.29%
May-19-26 04:05PM	Lost Money on TriSalus Life Sciences, Inc. (TLSI)? Possible Fraud - Contact Levi & Korsinsky Today (Newsfile)
May-14-26 01:03PM	Lost Money on TriSalus Life Sciences, Inc. (TLSI)? Contact Levi & Korsinsky to Protect Your Rights (Newsfile) -5.62%
May-13-26 01:01AM	TriSalus Life Sciences Inc (TLSI) Q1 2026 Earnings Call Highlights: Strategic Expansion and ... (GuruFocus.com) -41.45%
May-12-26 08:47PM	TriSalus Life Sciences, Inc. Q1 2026 Earnings Call Summary (Moby)
04:01PM	Loading…
04:01PM	TriSalus Life Sciences Reports First Quarter 2026 Results Demonstrating Commercial and Clinical Progress for Facilitating Long-Term Growth (Business Wire)
08:00AM	Real-World PEDD Study Published in the Journal of Comparative Effectiveness Research Shows Improved Clinical Outcomes and Meaningful Charge Avoidance (Business Wire)
May-11-26 09:21AM	Earnings To Watch: TriSalus Life Sciences Inc (TLSI) Reports Q1 2026 Result (GuruFocus.com)
May-04-26 05:24PM	TriSalus Life Sciences Announces Launch of PREDICTT Clinical Trial Evaluating Pressure-Enabled Drug Delivery in Liver Tumors (Business Wire)
Apr-28-26 04:05PM	TriSalus Life Sciences to Host First Quarter 2026 Financial Results Conference Call (Business Wire) -5.12%
Apr-09-26 04:05PM	TriSalus Life Sciences to Present New Data at the 2026 Society of Interventional Radiology Annual Scientific Meeting (Business Wire)
Apr-07-26 09:15AM	TriSalus Life Sciences Appoints Richard Marshall, M.D., as Chief Medical Officer (Business Wire)
Mar-18-26 08:00AM	TriSalus Life Sciences Announces Publication Demonstrating Enhanced Delivery and Immune Activation with Nelitolimod Delivered with Pressure-Enabled Drug Delivery in Liver Tumor Models (Business Wire)
Mar-06-26 08:30AM	TriSalus Life Sciences, Inc. Q4 2025 Earnings Call Summary (Moby) -6.39%
12:10AM	TriSalus Life Sciences Q4 Earnings Call Highlights (MarketBeat)
12:01AM	Loading…
12:01AM	TriSalus Life Sciences Inc (TLSI) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Mar-05-26 04:01PM	TriSalus Life Sciences Reports Fourth Quarter and Year-End 2025 Results and Reaffirms 2026 Revenue Guidance (Business Wire)
Mar-04-26 07:22AM	TriSalus Life Sciences Inc (TLSI) Q4 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Feb-25-26 04:05PM	TriSalus Life Sciences to Host Fourth Quarter 2025 Financial Results Conference Call (Business Wire)
Feb-20-26 08:00AM	TriSalus Life Sciences Announces Pricing of $40.0 Million Public Offering (Business Wire) +18.22%
Feb-19-26 04:01PM	TriSalus Life Sciences Proposes Public Offering (Business Wire)
Feb-09-26 09:00AM	TriSalus Life Sciences Appoints Veteran Healthcare Investor Michael Stansky to its Board of Directors (Business Wire)
Jan-14-26 12:00PM	TriSalus Life Sciences, Inc. (TLSI) Upgraded to Buy: Here's What You Should Know (Zacks)
Jan-12-26 07:00AM	TriSalus Life Sciences Announces Preliminary Fourth Quarter and Full-Year 2025 Results and 2026 Revenue Guidance (Business Wire)
Dec-04-25 04:01PM	TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Symptomatic Thyroid Disease on December 15, 2025 (Business Wire) +5.37%
Nov-18-25 08:00AM	TriSalus Life Sciences Launches TriNav XP Infusion System to Expand Options for Pressure-Enabled Drug Delivery (Business Wire)
Nov-14-25 12:04AM	TriSalus Life Sciences Inc (TLSI) Q3 2025 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com)
Nov-13-25 05:15PM	TriSalus Life Sciences, Inc. (TLSI) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:01PM	TriSalus Life Sciences Reports Third Quarter 2025 Results and Reaffirms 2025 Revenue Guidance (Business Wire)
Nov-12-25 07:29AM	TriSalus Life Sciences Inc (TLSI) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
07:10AM	Loading…
07:10AM	Rockwell Medical (RMTI) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
Nov-11-25 04:05PM	TriSalus Life Sciences to Participate in Upcoming Investor Conferences (Business Wire) +8.50%
Nov-10-25 08:00AM	TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Uterine Fibroids on November 12, 2025 (Business Wire) -8.88%
Nov-06-25 07:00PM	ICU Medical (ICUI) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
Nov-05-25 06:15PM	biote Corp. (BTMD) Tops Q3 Earnings and Revenue Estimates (Zacks) -5.32%
Oct-30-25 08:00AM	TriSalus Life Sciences to Host Third Quarter 2025 Financial Results Conference Call (Business Wire)
Aug-28-25 08:00AM	TriSalus Life Sciences to Participate in Upcoming September Investor Conferences (Business Wire)
Aug-13-25 03:12AM	TriSalus Life Sciences Inc (TLSI) Q2 2025 Earnings Call Highlights: Strong Sales Growth and ... (GuruFocus.com) +8.22%
Aug-12-25 05:10PM	TriSalus Life Sciences, Inc. (TLSI) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:01PM	TriSalus Life Sciences Reports Second Quarter 2025 Results and Reiterates 2025 Guidance (Business Wire)
Aug-11-25 07:00PM	Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -9.62%
09:37AM	Earnings To Watch: TriSalus Life Sciences Inc (TLSI) Reports Q2 2025 Result (GuruFocus.com)
08:00AM	TriSalus Life Sciences Announces Publication of Safety and Efficacy Results for a Novel Pressure-Enabled Thyroid Embolization Technique (Business Wire)
Aug-07-25 07:40AM	Zimmer Biomet (ZBH) Beats Q2 Earnings and Revenue Estimates (Zacks) -7.09%
Jul-30-25 04:05PM	TriSalus Life Sciences to Participate in the Canaccord Genuity 45th Annual Growth Conference (Business Wire)
Jul-29-25 04:05PM	TriSalus Life Sciences to Host Second Quarter 2025 Financial Results Conference Call (Business Wire)
Jul-24-25 05:58PM	TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock (Business Wire)
Jun-23-25 05:30PM	TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock to Streamline Capital Structure (Business Wire) -5.37%
Jun-04-25 08:00AM	TriSalus Life Sciences Announces the Launch of the TriNav FLX Infusion System (Business Wire)
May-30-25 07:00AM	TriSalus Life Sciences Announces Chief Financial Officer Transition With Appointment of David B. Patience (Business Wire) -8.76%
May-16-25 03:01PM	TriSalus Life Sciences Inc (TLSI) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
May-15-25 08:10AM	TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
07:00AM	TriSalus Life Sciences Reports First Quarter 2025 Results and Provides Updated 2025 Guidance (Business Wire)
May-12-25 07:15PM	OrganiGram (OGI) Reports Q2 Loss, Beats Revenue Estimates (Revised) (Zacks)
04:30PM	TriSalus Life Sciences to Host First Quarter 2025 Financial Results Conference Call (Business Wire)
07:45AM	OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
May-08-25 06:45PM	TerrAscend Corp. (TSNDF) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
Apr-30-25 08:15AM	SurModics (SRDX) Reports Q2 Loss, Misses Revenue Estimates (Zacks) -10.31%
08:00AM	TriSalus Life Sciences Announces $22.0 Million Private Placement Preliminary Q1 2025 Unaudited Financial Results (Business Wire)
Apr-10-25 11:33AM	VAREX IMAGING (VREX) Moves 16.5% Higher: Will This Strength Last? (Zacks)
Apr-09-25 08:47AM	TriSalus Life Sciences, Inc. (TLSI) Soars 6.6%: Is Further Upside Left in the Stock? (Zacks)
Mar-30-25 08:02AM	TriSalus Life Sciences: Optimistic Guidance For 2025, But There Are Still Risks (Seeking Alpha)
Mar-27-25 02:02PM	TriSalus Life Sciences, Inc. (TLSI) Q4 2024 Earnings Call Transcript (SeekingAlpha)
08:40AM	TriSalus Life Sciences, Inc. (TLSI) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:30AM	TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update (Business Wire)
Mar-26-25 08:00AM	TriSalus Life Sciences Announces New CMS HCPCS Code for TriNav Infusion System Mapping (Business Wire)
Mar-06-25 08:00AM	TriSalus Life Sciences Announces That Its Researchers Received Two JVIR Top Paper Awards for the Publication of "Intra-arterial Pressure-Enabled Drug Delivery Significantly Increases Penetration of Glass Microspheres in a Porcine Liver Tumor Model" (Business Wire)
Feb-03-25 04:05PM	TriSalus Life Sciences Announces Key Appointments to Board of Directors (Business Wire)
08:00AM	TriSalus Life Sciences Announces Drawdown of $10 Million Tranche Under Credit Agreement with OrbiMed (Business Wire)
Jan-23-25 08:00AM	TriSalus Life Sciences Announces Preliminary Q4 and Full Year Unaudited 2024 Financial Results and Conference Call (Business Wire) +5.31%
Jan-10-25 08:30AM	TriSalus Life Sciences announces publication of pre-clinical data (TipRanks) +7.95%
Jan-09-25 08:00AM	TriSalus Life Sciences Announces Publication of Pre-Clinical Data Demonstrating Improved Delivery of Embospheres to Liver Tumors using Pressure-Enabled Drug Delivery (PEDD) via the TriNav Infusion System (Business Wire)
Jan-08-25 08:00AM	TriSalus Announces Leadership Changes (Business Wire) -7.18%
Nov-14-24 08:00AM	TriSalus Reports Q3 2024 Financial Results and Provides Business Update (Business Wire) -10.89%
Nov-13-24 07:27AM	TriSalus Life Sciences Inc (TLSI) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Nov-11-24 07:00AM	TriSalus Life Sciences Forms Strategic Partnership with Geo-Med, LLC to Expand Access of the TriNav Infusion System to U.S. Veterans with Liver Cancer (Business Wire) +5.91%
Nov-07-24 07:00AM	TriSalus Life Sciences Launches TriNav LV Infusion System and TriGuide Guiding Catheters, Expanding Portfolio of PEDD Devices for Improved Tumor Treatment (Business Wire)
Oct-31-24 08:00AM	TriSalus Life Sciences to Host Third Quarter 2024 Financial Results Conference Call (Business Wire)
Oct-14-24 04:05PM	TriSalus Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit (Business Wire)
Sep-26-24 07:00AM	TriSalus Life Sciences Announces Appointment of Riad Salem, M.D., to its Scientific Advisory Board (Business Wire)
Sep-23-24 07:00AM	TriSalus Announces Journal of Vascular and Interventional Radiology Publication of Data that Demonstrate Improved Therapeutic Delivery of Glass Microspheres to Solid Tumors With PEDD Method via the TriNav Infusion System (Business Wire) -6.70%
Sep-14-24 01:52AM	TriSalus Life Sciences Inc (TLSI) CEO Buys Shares (GuruFocus.com)
Aug-15-24 08:00AM	TriSalus Reports Q2 2024 Financial Results and Business Update (Business Wire)
Aug-01-24 07:00AM	TriSalus Life Sciences to Host Second Quarter 2024 Financial Results Conference Call (Business Wire)
Jul-01-24 04:00PM	TriSalus Life Sciences Announces Completion of Exchange Offer and Consent Solicitation (Business Wire) -5.07%
Jun-26-24 05:45PM	TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Warrants (Business Wire)
Jun-03-24 07:00AM	TriSalus Life Sciences Highlights Clinical Data from Phase 1b PERIO-02 Trial, Studying Delivery of Nelitolimod via Pressure-Enabled Drug Delivery in Patients with Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma at 2024 ASCO Annual Meeting (Business Wire)
May-24-24 06:05AM	TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants (Business Wire) -20.75%
May-15-24 12:53PM	TLSI Stock Earnings: TriSalus Life Sciences Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) -7.49%
08:00AM	TriSalus Reports Q1 2024 Financial Results and Business Update (Business Wire)
May-07-24 07:00AM	TriSalus Life Sciences Appoints Liselotte Hyveled to its Board of Directors (Business Wire)
May-06-24 04:58PM	TriSalus Life Sciences to Host First Quarter 2024 Financial Results Conference Call (Business Wire)
Apr-30-24 04:35PM	TriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNav Infusion System Growth Initiatives (Business Wire)
Apr-01-24 12:53PM	TLSI Stock Earnings: TriSalus Life Sciences Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace) +5.13%
09:33AM	TriSalus Life Sciences Inc (TLSI) Q4 and Full Year 2023 Earnings: Revenue Growth Amidst Late ... (GuruFocus.com)
08:00AM	TriSalus Reports Q4 and Full Year 2023 Financial Results and Business Update (Business Wire)
Mar-26-24 08:00AM	TriSalus Life Sciences Technology Featured in Two Presentations at the Society of Interventional Radiology Annual Scientific Meeting (Business Wire)
Mar-21-24 08:00AM	TriSalus Life Sciences Announces Oral Presentations at the Upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting (Business Wire)
Mar-11-24 05:15PM	TriSalus Life Sciences Announces Q4 Conference Call and Preliminary and Unaudited Q4 and Full Year 2023 Financial Results (Business Wire)
Mar-07-24 07:00AM	TriSalus Life Sciences Receives Approval from the World Health Organization and the American Medical Associations Adopted Name Council for Nelitolimod as the Nonproprietary Drug Name for SD-101 (Business Wire)

TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The company was founded on September 11, 2020 and is headquartered in Westminster, CO.

M.B.A.Ms. Mary T. Szela B.S.N.

Chief Financial OfficerMr. David B. Patience

VMDDr. Richard B. Marshak M.B.A.

Vice President of MarketingAndrea Marasso

Chief RegulatoryMs. Jennifer L. Stevens J.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Marshak Richard	Chief Commercial Officer	May 15 '26	Sale	2.67	543	1,450	125,101	May 19 04:08 PM
Wahlstrom Mats	Director	May 15 '26	Buy	2.53	60,000	151,800	147,555	May 18 04:42 PM
Stansky Michael P	Director	May 15 '26	Buy	2.50	410,000	1,025,000	1,240,722	May 18 04:42 PM
Stansky Michael P	Director	May 15 '26	Buy	2.50	200,000	500,000	399,698	May 18 04:42 PM
Szela Mary T	CEO and President	May 15 '26	Buy	2.59	39,682	102,776	1,065,215	May 18 04:42 PM
Patience David	Chief Financial Officer	May 15 '26	Buy	2.43	7,100	17,253	275,757	May 18 04:42 PM
Gordon Gary B.	Director	May 15 '26	Buy	2.46	10,000	24,600	72,510	May 18 04:42 PM
Devlin Jodi	Chief of Clinical Operations	Mar 12 '26	Sale	4.09	1,772	7,247	97,637	Mar 20 04:25 PM
Devlin Jodi	Chief of Clinical Operations	Mar 11 '26	Sale	4.13	1,162	4,799	99,409	Mar 20 04:25 PM
Devlin Jodi	Chief of Clinical Operations	Mar 16 '26	Sale	4.12	273	1,125	97,364	Mar 20 04:25 PM
Cox Bryan F.	Chief of Research	Mar 12 '26	Sale	4.09	1,467	6,000	163,994	Mar 20 04:25 PM
Cox Bryan F.	Chief of Research	Mar 11 '26	Sale	4.13	1,138	4,700	165,461	Mar 20 04:25 PM
Cox Bryan F.	Chief of Research	Mar 16 '26	Sale	4.12	579	2,385	163,415	Mar 20 04:25 PM
Marshak Richard	Chief Commercial Officer	Mar 12 '26	Sale	4.09	1,589	6,499	110,816	Mar 20 04:25 PM
Marshak Richard	Chief Commercial Officer	Mar 11 '26	Sale	4.13	1,449	5,984	112,405	Mar 20 04:25 PM
Marshak Richard	Chief Commercial Officer	Mar 16 '26	Sale	4.12	419	1,726	110,397	Mar 20 04:25 PM
Stevens Jennifer	Chief Regulatory Officer	Mar 12 '26	Sale	4.09	1,552	6,348	124,884	Mar 20 04:25 PM
Stevens Jennifer	Chief Regulatory Officer	Mar 11 '26	Sale	4.13	1,204	4,973	126,436	Mar 20 04:25 PM
Stevens Jennifer	Chief Regulatory Officer	Mar 16 '26	Sale	4.12	774	3,189	124,110	Mar 20 04:25 PM
Szela Mary T	CEO and President	Mar 17 '26	Sale	3.85	15,944	61,384	752,987	Mar 20 04:25 PM
Szela Mary T	CEO and President	Mar 11 '26	Sale	4.13	4,358	17,999	768,931	Mar 20 04:25 PM
Patience David	Chief Financial Officer	Feb 23 '26	Buy	4.10	3,657	14,994	268,657	Feb 23 04:08 PM
Gordon Gary B.	Director	Feb 23 '26	Buy	4.10	9,756	40,000	9,756	Feb 23 04:08 PM
Valle William	Director	Feb 23 '26	Buy	4.10	30,487	124,997	30,487	Feb 23 04:08 PM
Szela Mary T	CEO and President	Feb 23 '26	Buy	4.10	30,487	124,997	773,289	Feb 23 04:08 PM
Stansky Michael P	Director	Feb 23 '26	Buy	4.10	243,900	999,990	787,132	Feb 23 04:08 PM
Stansky Michael P	Director	Feb 23 '26	Buy	4.10	117,198	480,512	199,698	Feb 23 04:08 PM

ABSI

Absci Corp

TLSI

TriSalus Life Sciences Inc

Upgrade your Finviz experience